JP Morgan Maintains Neutral on TransMedics Group, Raises Price Target to $149
Benzinga Newsdesk 8 months ago
NewsPrice TargetAnalyst Ratings
JP Morgan analyst Allen Gong maintains TransMedics Group (NASDAQ:TMDX) with a Neutral and raises the price target from $114 to $149.
JP Morgan analyst Allen Gong maintains TransMedics Group (NASDAQ:TMDX) with a Neutral and raises the price target from $114 to $149.